Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up
As Pfizer sells its stake in ViiV Healthcare, Japan-based Shionogi & Co will increase its hold in the human immunodeficiency…
News
GSK acquires RAPT Therapeutics for $2.2bn
DeepHow introduces PharmaCloud for pharmaceutical manufacturers
iRegene receives FDA RMAT designation for NouvNeu001 to treat Parkinson’s
UK’s pharma outlook buoyed by trans-Atlantic trade policies
Compounder sues Lilly and Novo for suppressing GLP-1RA competition
AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy
FDA grants Novartis’ ianalumab breakthrough therapy status for Sjögren’s disease
